Sectoral Asset Management INC Lowered Position in Pfizer INC (PFE) as Stock Declined

April 23, 2018 - By Nellie Frank

Pfizer Inc. (NYSE:PFE) LogoInvestors sentiment increased to 1.06 in 2017 Q4. Its up 0.10, from 0.96 in 2017Q3. It improved, as 51 investors sold PFE shares while 675 reduced holdings. 134 funds opened positions while 632 raised stakes. 4.07 billion shares or 0.28% more from 4.06 billion shares in 2017Q3 were reported. Tarbox Family Office, a California-based fund reported 37,816 shares. Northern Tru accumulated 79.76M shares or 0.73% of the stock. London Of Virginia invested in 6.30M shares or 1.65% of the stock. Cullen Frost Bankers Incorporated holds 0.3% or 262,794 shares in its portfolio. 6.82M were accumulated by Adage Cap Prtn Group Ltd Liability Corporation. 15.38M are held by California Pub Employees Retirement System. Sterneck Management Ltd Company owns 0.88% invested in Pfizer Inc. (NYSE:PFE) for 40,705 shares. 13.50M were reported by Schroder Mgmt. Bontempo Ohly Capital Mgmt Lc owns 89,444 shares. Kelly Lawrence W & Ca accumulated 20,733 shares. Valueworks Limited Company reported 2.54% in Pfizer Inc. (NYSE:PFE). Pillar Pacific Cap Management Ltd Llc accumulated 14,055 shares. Asset Mngmt Of Georgia Ga Adv holds 1.37% or 53,122 shares in its portfolio. Tnb has 65,787 shares for 0.45% of their portfolio. Mogy Joel R Counsel holds 0.81% or 142,954 shares in its portfolio.

Since December 15, 2017, it had 0 insider purchases, and 12 insider sales for $12.99 million activity. SUSMAN SALLY sold $1.24 million worth of stock or 33,368 shares. LANKLER DOUGLAS M had sold 50,000 shares worth $1.84 million. 9,510 shares were sold by LUND-JURGENSEN KIRSTEN, worth $353,677. Another trade for 1,758 shares valued at $64,679 was sold by CORNWELL W DON. HILL CHARLES H sold 26,779 shares worth $986,292. $501,398 worth of Pfizer Inc. (NYSE:PFE) was sold by Dolsten Mikael.

Jerome Pfund decreased its stake in Pfizer Inc (PFE) by 9.15% based on its latest 2017Q4 regulatory filing with the SEC. Sectoral Asset Management Inc sold 87,599 shares as the company’s stock declined 3.13% with the market. The hedge fund run by Jerome Pfund held 870,074 shares of the health care company at the end of 2017Q4, valued at $31.51M, down from 957,673 at the end of the previous reported quarter. Sectoral Asset Management Inc who had been investing in Pfizer Inc for a number of months, seems to be less bullish one the $218.67B market cap company. The stock increased 0.35% or $0.13 during the last trading session, reaching $36.76. About 986,083 shares traded. Pfizer Inc. (NYSE:PFE) has risen 2.43% since April 23, 2017 and is uptrending. It has underperformed by 9.12% the S&P500.

Sectoral Asset Management Inc, which manages about $3.30B and $800.30 million US Long portfolio, upped its stake in La Jolla Pharmaceutical (NASDAQ:LJPC) by 252,801 shares to 854,301 shares, valued at $27.49 million in 2017Q4, according to the filing. It also increased its holding in Sarepta Therapeutics (NASDAQ:SRPT) by 169,900 shares in the quarter, for a total of 238,999 shares, and has risen its stake in Acadia Pharmaceuticals (NASDAQ:ACAD).

Analysts await Pfizer Inc. (NYSE:PFE) to report earnings on May, 1 before the open. They expect $0.73 EPS, up 5.80 % or $0.04 from last year’s $0.69 per share. PFE’s profit will be $4.34B for 12.59 P/E if the $0.73 EPS becomes a reality. After $0.62 actual EPS reported by Pfizer Inc. for the previous quarter, Wall Street now forecasts 17.74 % EPS growth.

Pfizer Inc. (NYSE:PFE) Ratings Coverage

Among 11 analysts covering Pfizer (NYSE:PFE), 5 have Buy rating, 1 Sell and 5 Hold. Therefore 45% are positive. Pfizer has $54.0 highest and $3800 lowest target. $41’s average target is 11.53% above currents $36.76 stock price. Pfizer had 16 analyst reports since October 26, 2017 according to SRatingsIntel. The stock has “Hold” rating by SunTrust on Sunday, January 28. On Thursday, October 26 the stock rating was maintained by Jefferies with “Hold”. On Monday, February 26 the stock rating was maintained by Jefferies with “Hold”. The rating was maintained by Piper Jaffray with “Buy” on Tuesday, October 31. The rating was maintained by Morgan Stanley on Wednesday, January 31 with “Overweight”. The stock of Pfizer Inc. (NYSE:PFE) earned “Buy” rating by UBS on Wednesday, November 1. As per Thursday, April 5, the company rating was downgraded by Barclays Capital. BMO Capital Markets maintained the shares of PFE in report on Tuesday, November 21 with “Buy” rating. The rating was maintained by Jefferies with “Hold” on Tuesday, January 16. Jefferies maintained it with “Hold” rating and $3800 target in Friday, April 13 report.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: